Market Insights Health Pharmacies OTC Products

Cold & Cough Remedies (Pharmacies) - D-A-CH

D-A-CH

Revenue in the Cold & Cough Remedies market is projected to reach US$1.48bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.79%, resulting in a market volume of US$1.87bn by 2029.
In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
In relation to total population figures, per person revenues of US$14.60 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in D-A-CH, which includes Germany, Austria, and Switzerland, is experiencing significant growth due to several factors.

Customer preferences: Customers in the D-A-CH region have a strong preference for over-the-counter remedies for cold and cough symptoms. They value convenience and accessibility, which is why they often turn to pharmacies for their healthcare needs. Pharmacies in the D-A-CH region are well-stocked with a wide range of cold and cough remedies, providing customers with plenty of options to choose from. Additionally, customers in this region are increasingly seeking natural and herbal remedies, driving the demand for products that are perceived as more holistic and gentle on the body.

Trends in the market: One major trend in the D-A-CH market for cold and cough remedies is the increasing demand for products that offer multiple benefits. Customers are looking for remedies that not only relieve cold and cough symptoms but also boost their immune system and overall well-being. This has led to the development of combination products that contain ingredients such as vitamins, minerals, and herbal extracts. Another trend is the growing popularity of online pharmacies, which offer convenience and competitive pricing. Customers in the D-A-CH region are increasingly purchasing cold and cough remedies online, further driving the growth of this market.

Local special circumstances: In Germany, the largest market in the D-A-CH region, there is a strong emphasis on natural and alternative medicine. Many customers prefer herbal remedies and homeopathic treatments for cold and cough symptoms. This preference for natural remedies is also reflected in the regulations governing the sale of over-the-counter products in Germany. In Austria, there is a strong tradition of self-medication, with customers often relying on pharmacies for advice and guidance on choosing the right cold and cough remedies. In Switzerland, the market is characterized by a high level of competition among pharmacies, leading to a wide variety of products and competitive pricing.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in D-A-CH is influenced by several macroeconomic factors. These include the increasing prevalence of cold and cough symptoms due to changing weather patterns and environmental factors. Additionally, the aging population in the D-A-CH region is driving the demand for cold and cough remedies, as older individuals are more susceptible to respiratory illnesses. Furthermore, the rising healthcare costs and the desire to avoid unnecessary doctor visits are also contributing to the growth of the market, as customers prefer to self-medicate with over-the-counter remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in D-A-CH is experiencing growth due to customer preferences for over-the-counter remedies, the development of combination products, the rise of online pharmacies, and the emphasis on natural and alternative medicine. The local special circumstances in each country, such as the preference for natural remedies in Germany and the tradition of self-medication in Austria, further contribute to the growth of the market. The underlying macroeconomic factors, including the increasing prevalence of cold and cough symptoms and the aging population, also play a significant role in driving the demand for cold and cough remedies in the D-A-CH region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.